Access cutting-edge solid tumors treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).
Sponsor: Immatics US, Inc.
Check if you qualify for this solid tumors clinical trial in Miami, FL
If you're searching for solid tumors treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.